Cargando…
Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acui...
Autores principales: | Lim, Sarah, Tignanelli, Christopher J, Hoertel, Nicolas, Boulware, David R, Usher, Michael G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384640/ https://www.ncbi.nlm.nih.gov/pubmed/36000003 http://dx.doi.org/10.1093/ofid/ofac389 |
Ejemplares similares
-
Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
por: Hoertel, Nicolas, et al.
Publicado: (2022) -
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
por: Hammond, Jennifer, et al.
Publicado: (2022) -
Possible medication error risks with nirmatrelvir+ritonavir
Publicado: (2022) -
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022)